Clinical Trials Logo
  1. Home
  2. Liver Metastasis
  3. NCT02728167

Efficacy of HIFU-AR on Blood Loss Reduction in Patients With Liver Metastases Requiring Hepatectomy — HIFU-AR  

Liver Metastasis Clinical Trial

Official title:
Randomized, Open-label, Phase II Study to Evaluate the Efficacy of High-Intensity Focused Ultrasound Assisted Hepatic Resection (HIFU-AR) on Blood Loss Reduction in Patients With Liver Metastases Requiring Hepatectomy

Clinical Trial Summary

The purpose of this study is to evaluate whether HIFU-assisted liver resection (HIFU-AR) results in reduced blood loss compared to standard liver resection in patients with LM.This is a prospective, monocentric, randomized (1:1 ratio), comparative, open-label Phase II study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02728167
Study type Interventional
Source Centre Leon Berard
Contact
Status Terminated
Phase N/A
Start date April 2016
Completion date August 2018
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05524155 - Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis Phase 2
Recruiting NCT02632201 - Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis Phase 1/Phase 2
Enrolling by invitation NCT01715402 - Optimization of Health Expenditure in Liver Surgery N/A
Recruiting NCT01035385 - Compare FOFLOX4 in Preoperative and Postoperative and Postoperative in Resectable Liver Metastasis Colorectal Cancer (MCC) Phase 3
Recruiting NCT05098847 - Cryoablation Combined With Sintilimab Plus Lenvatinib In Previously Treated Unresectable Liver Metastasis From Solid Tumors Phase 2
Withdrawn NCT02651090 - Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced CT and/or MRI Phase 3
Withdrawn NCT01775280 - Response of Hepatic Tumors to Radioembolization Phase 2
Completed NCT00068068 - Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases Phase 2
Terminated NCT02453490 - Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis Phase 3
Recruiting NCT04622423 - Advanced Therapies for Liver Metastases
Completed NCT00892424 - Sorafenib-RT Treatment for Liver Metastasis (SLIM) Phase 1/Phase 2
Completed NCT00028405 - Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors Phase 1
Completed NCT03801915 - Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers Phase 2
Completed NCT02218801 - A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program
Completed NCT01834014 - Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases N/A
Completed NCT00083785 - Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases Phase 2
Active, not recruiting NCT03428477 - EPA for Metastasis Trial 2 Phase 3
Completed NCT02316028 - Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC) Phase 1/Phase 2
Completed NCT01785212 - The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver N/A
Completed NCT03785210 - Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers Phase 2